LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 21.40 | 84.90 | 1026 | 1454 | 0.7053 | 0.8367 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 21.40 | 84.90 | 437 | 1454 | 0.3004 | 0.4915 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 21.40 | 84.90 | 850 | 1454 | 0.5843 | 0.7543 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 23.10 | 84.90 | 902 | 1616 | 0.5581 | 0.7436 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 23.10 | 84.90 | 1018 | 1616 | 0.6299 | 0.7939 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 23.10 | 84.90 | 455 | 1616 | 0.2815 | 0.4843 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 23.10 | 84.90 | 911 | 1616 | 0.5637 | 0.7477 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 24.81 | 84.90 | 979 | 1769 | 0.5533 | 0.7473 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 24.81 | 84.90 | 1081 | 1769 | 0.6109 | 0.7872 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 24.81 | 84.90 | 554 | 1769 | 0.3131 | 0.5343 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 24.81 | 84.90 | 940 | 1769 | 0.5312 | 0.7311 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 26.51 | 84.90 | 972 | 1923 | 0.5054 | 0.7187 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 26.51 | 84.90 | 1048 | 1923 | 0.5449 | 0.7477 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 26.51 | 84.90 | 620 | 1923 | 0.3224 | 0.5553 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 26.51 | 84.90 | 914 | 1923 | 0.4753 | 0.6954 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 28.21 | 84.90 | 1021 | 2091 | 0.4882 | 0.7126 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 28.21 | 84.90 | 1094 | 2091 | 0.5231 | 0.7384 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 28.21 | 84.90 | 673 | 2091 | 0.3218 | 0.5650 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 28.21 | 84.90 | 961 | 2091 | 0.4595 | 0.6903 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.92 | 84.90 | 1019 | 2237 | 0.4554 | 0.6930 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.92 | 84.90 | 1081 | 2237 | 0.4831 | 0.7143 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.92 | 84.90 | 700 | 2237 | 0.3128 | 0.5635 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 29.92 | 84.90 | 936 | 2237 | 0.4183 | 0.6628 | MN20160318_Q02 | F10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 31.62 | 84.90 | 1025 | 2449 | 0.4184 | 0.6712 | MN20160318_Q02 | C04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 31.62 | 84.90 | 1074 | 2449 | 0.4384 | 0.6874 | MN20160318_Q02 | C04 |